CGNU PLC
18 February 2002
CGNU sells its Portuguese general insurance business
CGNU plc ('CGNU') has agreed the sale of its Portuguese general insurance
operation, a branch of CGU International Insurance plc (CGUII), to Victoria
Seguros SA, a subsidiary of the Ergo Group. The net asset value of the
business as at 31 December 2000 was Euros 4.6 million.
CGUII's Portuguese branch is a general insurer focused on personal lines.
In 2000 it had gross written premiums of Euros 21 million.
The disposal is consistent with CGNU's strategy of building top five positions
in its chosen markets and withdrawing from operations where it does not have
sufficient scale to achieve this.
The transaction is subject to regulatory approval and is expected to complete
in the second quarter of 2002.
Enquiries:
Analysts/Investors
Steve Riley, Investor Relations Director, CGNU +44 (0) 20 7662 8115
Media
Ian Frater, Head of Group Media Relations, CGNU +44 (0) 20 7662 8221
Alex Child-Villiers, Financial Dynamics +44 (0) 20 7269 7107
Notes to editors
* CGNU plc is the world's seventh largest insurance group and the largest
insurer in the UK
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.